ATE321552T1 - 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung - Google Patents

1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung

Info

Publication number
ATE321552T1
ATE321552T1 AT00969904T AT00969904T ATE321552T1 AT E321552 T1 ATE321552 T1 AT E321552T1 AT 00969904 T AT00969904 T AT 00969904T AT 00969904 T AT00969904 T AT 00969904T AT E321552 T1 ATE321552 T1 AT E321552T1
Authority
AT
Austria
Prior art keywords
substituents
group optionally
hydrocarbon group
prostatism
steroid
Prior art date
Application number
AT00969904T
Other languages
English (en)
Inventor
Akihiro Tasaka
Tomohiro Kaku
Masami Kusaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE321552T1 publication Critical patent/ATE321552T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
AT00969904T 1999-10-22 2000-10-19 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung ATE321552T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30156299 1999-10-22

Publications (1)

Publication Number Publication Date
ATE321552T1 true ATE321552T1 (de) 2006-04-15

Family

ID=17898444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00969904T ATE321552T1 (de) 1999-10-22 2000-10-19 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung

Country Status (7)

Country Link
US (1) US6518257B1 (de)
EP (1) EP1227086B1 (de)
AT (1) ATE321552T1 (de)
AU (1) AU7950100A (de)
CA (1) CA2388508A1 (de)
DE (1) DE60027034T2 (de)
WO (1) WO2001030764A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE502030T1 (de) * 2000-11-20 2011-04-15 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
WO2002046186A1 (en) * 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
WO2003015820A1 (en) * 2001-08-10 2003-02-27 Takeda Chemical Industries, Ltd. GnRH AGONIST COMBINATION DRUGS
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
MX2007015679A (es) * 2005-06-30 2008-02-21 Amgen Inc Inhibidores de quinasa bis-aril y su uso en el tratamiento de inflamacion, angiogenesis y cancer.
NZ572374A (en) 2006-03-29 2011-12-22 Univ California Diarylthiohydantoin compounds
EP2220050A2 (de) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoinverbindungen als androgenrezeptormodulatoren
EP2674417A3 (de) 2007-11-21 2014-04-09 Decode Genetics EHF Biaryl-PDE4-Inhibitoren zur Behandlung von Entzündungen
AU2008326381B2 (en) * 2007-11-21 2014-10-23 Decode Genetics Ehf Biaryl PDE4 inhibitors for treating inflammation
WO2010059838A2 (en) * 2008-11-20 2010-05-27 Decode Genetics Ehf Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
TWI640519B (zh) * 2011-11-29 2018-11-11 泰緯生命科技股份有限公司 Ｈｅｃ１活性調控因子及其調節方法
KR101735787B1 (ko) 2013-02-28 2017-05-16 주식회사 티움바이오 삼환식 화합물 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
AU7275894A (en) 1993-08-04 1995-02-28 Yamanouchi Pharmaceutical Co., Ltd. Imidazolylalkylamine derivative and pharmaceutical composition thereof
CN1131944A (zh) * 1993-09-30 1996-09-25 山之内制药株式会社 唑类衍生物和它的药物组合物
PL322028A1 (en) * 1995-03-01 1998-01-05 Yamanouchi Pharma Co Ltd Derivatives of imidazoles and pharmaceutic composition containing them
AU716123B2 (en) * 1996-04-03 2000-02-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
ATE264304T1 (de) 1997-10-02 2004-04-15 Daiichi Seiyaku Co Dihydronaphthalinderivate und verfahren zur herstellung derselben
ATE293102T1 (de) * 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung

Also Published As

Publication number Publication date
US6518257B1 (en) 2003-02-11
WO2001030764A1 (en) 2001-05-03
EP1227086A4 (de) 2002-10-28
DE60027034D1 (de) 2006-05-18
EP1227086B1 (de) 2006-03-29
DE60027034T2 (de) 2006-11-09
EP1227086A1 (de) 2002-07-31
CA2388508A1 (en) 2001-05-03
AU7950100A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
ATE440096T1 (de) Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
DE60027034D1 (de) 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
DE69416629D1 (de) 2-Piperazinon-Verbindungen und deren Verwendung
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
PT99134A (pt) Processo para a preparacao de derivados da piperazina
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
ATE524432T1 (de) Aminverbindung und deren verwendung für medizinische zwecke
DE69521687D1 (de) 4-indol-1-yl-buttersäure derivate, deren herstellung und deren verwendung als inhibitoren für alpha1-adrenerge rezeptoren und testosteron 5alpha-reduktasen
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
DE3867899D1 (de) Verfahren zur herstellung von 4-amino-androstendion-derivaten.
ATE502030T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
ATE256108T1 (de) Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
DE69818051D1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
DK0504290T3 (da) Inhibitorer af dihydrofylatreduktase fra Pneumocystis carinii
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
ATE420067T1 (de) Peptid-derivate und ihre pharmazeutisch akzeptablensalze, verfahren zur herstellung von beiden und ihre verwendung
ATE449780T1 (de) Derivate von ä2-(8,9-dioxo-2,6- diazabicycloä5.2.0ünon-1(7)-en-2- yl)alkylüphosphonsäure und verfahren zu deren herstellung
MX2025013810A (es) Composicion para la prevencion o el tratamiento del dolor por cancer
PT1192191E (pt) Processo para o fabrico de compostos de condensacao

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties